Maryam Mahmood

Dr. Maryam Mahmood

Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, MN, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2017 in Journal of Nuclear Cardiology
Verified
Journal Article
Closed access
PDF file
Maryam MahmoodMaryam Mahmood
Maryam Mahmood
AKAyse Tuba Kendi
Ayse Tuba Kendi
SASaira Ajmal
Saira Ajmal
SFSaira Farid
Saira Farid
JOJohn C. O’hOro
John C. O’hOro
MSMuhammad Rizwan Sohail
Muhammad Rizwan Sohail

1 September 2020 in Mayo Clinic Proceedings
Verified
Journal Article
Closed access
ZTZelalem M. Temesgen
Zelalem M. Temesgen
DDDaniel C. DeSimone
Daniel C. DeSimone
Maryam MahmoodMaryam Mahmood
Maryam Mahmood
CLClaudia R. Libertin
Claudia R. Libertin
BPBharath Raj Varatharaj Palraj
Bharath Raj Varatharaj Palraj
EBElie F. Berbari
Elie F. Berbari

14 September 2017 in Journal of Nuclear Cardiology
Verified
Journal Article
Closed access
PDF file
Maryam MahmoodMaryam Mahmood
Maryam Mahmood
AKAyse Tuba Kendi
Ayse Tuba Kendi
SFSaira Farid
Saira Farid
SASaira Ajmal
Saira Ajmal
GJGeoffrey B. Johnson
Geoffrey B. Johnson
MSMuhammad Rizwan Sohail
Muhammad Rizwan Sohail

1 January 2015 in North American Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
RPRanjan Pathak
Ranjan Pathak
DPDilli Ram Poudel
Dilli Ram Poudel
PKParas Karmacharya
Paras Karmacharya
APAmrit Pathak
Amrit Pathak
Maryam MahmoodMaryam Mahmood
Maryam Mahmood
ADAnthonyA Donato
AnthonyA Donato
Background: The current West Africa epidemic of Ebola virus disease (EVD), which began from Guinea in December 2013, has been the longest and deadliest Ebola outbreak to date. With the propagation of the internet, public health officials must now compete with other official and unofficial sources of information to get their message out. Aims: This study aimed at critically appraising videos available on one popular internet video site (YouTube) as a source of information for Ebola virus disease (EVD). Materials and Methods: Videos were searched in YouTube (http://www.youtube.com) using the keyword "Ebola outbreak" from inception to November 1, 2014 with the default "relevance" filter. Only videos in English language under 10 min duration within first 10 pages of search were included. Duplicates were removed and the rest were classified as useful or misleading by two independent reviewers. Video sources were categorized by source. Inter-observer agreement was evaluated with kappa coefficient. Continuous and categorical variables were analyzed using the Student t-test and Chi-squared test, respectively. Results: One hundred and eighteen out of 198 videos were evaluated. Thirty-one (26.27%) videos were classified as misleading and 87 (73.73%) videos were classified as useful. The kappa coefficient of agreement regarding the usefulness of the videos was 0.68 (P < 0.001). Independent users were more likely to post misleading videos (93.55% vs 29.89%, OR = 34.02, 95% CI = 7.55-153.12, P < 0.001) whereas news agencies were most likely to post useful videos (65.52% vs 3.23%, OR = 57.00, 95% CI = 7.40-438.74, P < 0.001). Conclusions: This study demonstrates that majority of the internet videos about Ebola on YouTube were characterized as useful. Although YouTube seems to generally be a useful source of information on the current outbreak, increased efforts to disseminate scientifically correct information is desired to prevent unnecessary panic among the among the general population.

11 February 2022 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
Hussam TabajaHussam Tabaja
Hussam Tabaja
AKAmjad Kanj
Amjad Kanj
SZSaid El Zein
Said El Zein
ICIsin Yagmur Comba
Isin Yagmur Comba
OCOmar Chehab
Omar Chehab
Maryam MahmoodMaryam Mahmood
Maryam Mahmood
We provide an elaborate review of cases published between January 2005 and April 2021 on hemophagocytic lymphohistiocytosis (HLH) in HIV patients. Seventy articles describing 81 adult patients (age ≥19 years) were included. The median age was 40 years, and 78% were males. Only 65% were known to have HIV before presentation. CD4 count was ≥200 cells/mm3 in 23%, and HIV viral load was <200 copies/mL in 41%. The lack of meticulous reporting of ≥5 of 8 criteria for HLH diagnosis was evident in a third of cases. At least 1 infectious agent—other than HIV—was believed to trigger HLH in 78% of patients. The most common were Epstein-Barr virus (26%), human herpesvirus 8 (21%), and Histoplasma capsulatum (17%). Sixty percent survived. Among those, 93% received treatment for identified secondary trigger(s), while 51% received HLH-directed therapy. There was significant heterogeneity in the treatment regimens used for HLH.

29 May 2022 in Cureus
Verified
Journal Article
Open access
JHJoya-Rita Hindy
Joya-Rita Hindy
Juan A Quintero-MartinezJuan A Quintero-Martinez
Juan A Quintero-Martinez
ALAlexander T. Lee
Alexander T. Lee
CSChristopher Scott
Christopher Scott
DGDanielle J. Gerberi
Danielle J. Gerberi
LBLarry M. Baddour
Larry M. Baddour
Objectives: To determine incidence trends of Staphylococcus aureus bacteremia (SAB) from population-based studies from multiple countries. Methods: A contemporary systematic review was conducted using Ovid Cochrane Central Register of Controlled Trials (1991+), Ovid Embase (1974+), Ovid Medical Literature Analysis and Retrieval System Online (MEDLINE) (1946+ including epub ahead of print, in-process & other non-indexed citations), and Web of Science Core Collection (Science Citation Index Expanded 1975+ and Emerging Sources Citation Index 2015+). Two authors (J.R.H. and J.A.Q.M.) independently reviewed all studies and included those that reported population-based incidence of SAB in patients aged 18 years and older. Results: Twenty-six studies met inclusion criteria with the highest number (n=6) of studies conducted in Canada. The incidence of SAB ranged from 9.3 to 65 cases/100,000/year. The median age of patients with SAB ranged from 62 to 72 years and SAB cases were more commonly observed in men than in women. The most common infection sources were intravascular catheters and skin and soft tissue infections. SAB incidence trends demonstrated high variability for geographic regions and calendar years. Overall, there was no change in the incidence trend across all studies during the past two decades. Conclusion: Multiple factors, both pros, and cons are likely responsible for the overall stable SAB incidence in countries included in this systematic review. Some of these factors vary in geographic location and prompt additional investigations from countries not included in the current review so that a more global characterization is defined.